SYN Chart
- 52-Week Range: $0.20 - $0.72
- Market Capitalization: $34.84M
- Short Percentage: 0%
- Target Price: $1.63
- Shares Outstanding: 158.44M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
SYN released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Synthetic Biologics Reports First Quarter 2022 Operational Highlights and Financial ResultsGlobeNewsWire | May 16th
- Synthetic Biologics Announces Management Transitions in Support of Strategic TransformationGlobeNewsWire | March 23rd
- Synthetic Biologics to Participate in the Maxim 2022 Virtual Growth ConferenceGlobeNewsWire | March 22nd
- Synthetic Biologics, Inc. (SYN) CEO Steven Shallcross on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 16th
- Synthetic Biologics Reports 2021 Year End Operational Highlights and Financial ResultsGlobeNewsWire | March 16th
Company Info
Website: https://www.syntheticbiologics.com
Address: 9605 Medical Center Drive, Rockville, MD, United States, 20850
Sector: Healthcare
Industry: Biotechnology
Full time employees: 16
Address: 9605 Medical Center Drive, Rockville, MD, United States, 20850
Sector: Healthcare
Industry: Biotechnology
Full time employees: 16
$SYN diamond balls
$SYN I like it
$SYN what time we going green?
$SYN who here can't stand the CEO?
$SYN Bears go home!
$SYN Growth/Value